Ignite Creation Date:
2025-12-25 @ 3:33 AM
Ignite Modification Date:
2026-03-03 @ 10:05 AM
Study NCT ID:
NCT03079505
Status:
TERMINATED
Last Update Posted:
2019-01-23
First Post:
2017-03-08
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Dasatinib Versus Nilotinib for Treatment Naïve Chronic Myeloid Leukemia
Sponsor:
Hamad Medical Corporation
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
17095/17
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None